Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Neurogastroenterol Motil. 2013 Feb 17;25(5):427–e301. doi: 10.1111/nmo.12091

Table 2.

RELATION OF UPPER ABDOMINAL PAIN/UPPER ABDOMINAL DISCOMFORT TO BASELINE CHARACTERISTICS IN DIABETIC AND IDIOPATHIC GASTROPARESIS

Diabetic Gastroparesis Idiopathic Gastroparesis
Characteristic Upper Abdominal
Pain/Upper
Abdominal
Discomfort Score ≥3
N=92
Upper Abdominal
Pain/Upper
Abdominal
Discomfort Score <3
N=45
P Upper Abdominal
Pain/Upper
Abdominal
Discomfort Score ≥3
N=196
Upper Abdominal
Pain/Upper
Abdominal
Discomfort Score <3
N=60
P
Demographic and clinical factors Age at enrollment (years) 43.8±13.2 47.5±12.4 0.112 41.3±13.6 40.6±15.7 0.73
Female sex 70 (76%) 30 (67%) 0.31 176 (90%) 51 (85%) 0.35
Hispanic ethnicity 8 (9%) 4 (9%) 1.00 6 (3%) 1 (2%) 1.00
Race:
White
Black
Other
 
69 (76%)
18 (20%)
4 (4%)
 
36 (84%)
5 (12%)
2 (5%)
0.47  
180 (93%)
9 (5%)
5 (3%)
 
52 (87%)
6 (10%)
2 (3%)
0.20
Acute symptom onset 45 (50%) 28 (64%) 0.143 100 (51%) 30 (50%) 0.89
Initial infectious prodrome 11 (12%) 8 (18%) 0.43 33 (17%) 15 (25%) 0.189
Gastroparesis severity measures Clinician-rated severity:
Grade 1
Grade 2
Grade 3
 
2 (2%)
46 (50%)
44 (48%)
 
10 (23%)
17 (39%)
17 (39%)
<0.001  
25 (13%)
110 (57%)
59 (30%)
 
12 (20%)
35 (58%)
13 (22%)
0.24
GCSI:
Overall
Nausea/vomiting subscale
Fullness/satiety subscale
Bloating subscale
 
3.3±0.8
3.1±1.3
3.5±0.9
3.3±1.5
 
2.2±1.0
2.2±1.6
2.4±1.2
2.0±1.5
 
<0.001
<0.001
<0.001
<0.001
 
3.3±0.9
2.6±1.4
3.8±0.9
3.4±1.5
 
2.1±0.9
1.7±1.4
2.6±1.1
2.1±1.5
 
<0.001
<0.001
<0.001
<0.001
PAGI-SYM:
Lower abdominal pain
Lower discomfort
Constipation
Diarrhea
 
2.6±1.5
2.7±1.5
2.7±1.6
2.1±1.8
 
0.9±1.1
1.2±1.2
1.6±1.6
1.6±1.5
 
<0.001
<0.001
<0.001
0.129
 
2.4±1.6
2.5±1.7
2.8±1.8
2.1±1.7
 
1.4±1.5
1.6±1.6
1.5±1.6
1.3±1.5
 
<0.001
<0.001
<0.001
0.003
Quality of life measures PAGI-QOL 2.1±1.1 3.2±1.0 <0.001 2.2±1.0 3.3±0.9 <0.001
SF-36:
Physical component
Mental component
 
29.0±9.0
32.6±11.7
 
35.9±9.6
41.5±12.7
 
<0.001
<0.001
 
31.9±9.1
35.8±12.2
 
40.5±11.1
42.9±12.0
 
<0.001
<0.001
BPI:
Pain interference score
General activity
Mood
Walking ability
Normal work
Relations with people
Sleep
Enjoyment of life
 
6.2±2.4
6.3±2.7
6.6±2.7
5.2±3.0
6.7±2.7
5.4±3.1
6.3±3.1
6.8±3.1
 
4.4±2.8
4.1±3.6
4.2±3.4
4.5±3.2
5.8±3.3
3.3±3.2
4.4±3.9
4.8±3.3
 
0.003
0.001
<0.001
0.31
0.185
0.004
0.013
0.006
 
5.7±2.5
5.8±3.1
6.2±2.9
4.5±3.2
6.1±3.2
5.0±3.3
6.2±3.2
6.4±3.1
 
3.3±2.6
3.4±3.0
3.7±2.9
2.1±2.8
3.5±3.3
3.2±3.0
3.1±3.0
3.9±3.2
 
<0.001
<0.001
<0.001
<0.001
<0.001
0.004
<0.001
<0.001
Parameters of psychological dysfunction BDI 22.8±11.9 15.0±9.7 <0.001 20.4±11.0 13.7±9.1 <0.001
STAI:
Y1 state anxiety
Y2 trait anxiety
 
49.9±13.0
48.5±12.3
 
39.1±12.2
40.2±12.4
 
<0.001
<0.001
 
46.9±13.5
45.4±12.2
 
40.0±11.7
39.3±10.9
 
<0.001
<0.001
Gastric emptying Gastric retention (%):
2 hour
4 hour
 
67.4±21.7
40.3±26.5
 
66.0±20.5
41.7±27.0
 
0.71
0.77
 
62.9±16.1
29.2±19.0
 
63.3±18.0
25.9±18.0
 
0.89
0.24
Medication use Prokinetics
Antiemetics
Opiates
Pain modulators
Antidepressants
64 (70%)
66 (72%)
49 (53%)
24 (26%)
37 (40%)
28 (62%)
28 (62%)
15 (33%)
13 (29%)
15 (33%)
0.44
0.33
0.031
0.84
0.46
93 (48%)
125 (64%)
89 (46%)
35 (18%)
72 (37%)
33 (55%)
30 (50%)
20 (33%)
6 (10%)
19 (32%)
0.31
0.056
0.092
0.164
0.54
Diabetes-related factors Neuropathy
Hemoglobin A1c (%)
35 (38%)
7.9±2.0
21 (47%)
7.9±2.0
0.33
0.99

All data are mean±SD or N (%)

GCSI: Gastroparesis Cardinal Symptom Index

PAGI-SYM: Patient Assessment of Upper Gastrointestinal Disorders Symptoms

PAGI-QOL: Patient Assessment of Upper Gastrointestinal Disorders Quality of Life

SF-36: Short Form-36

BPI: Brief Pain Inventory

BDI: Beck Depression Inventory

STAI: State and Trait Anxiety Inventory